Document Details
Form
Filing Date
Oct 03, 2024
Document Date
Sep 17, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.